Lala Gregorek has broad experience as a life sciences analyst gained at Canaccord Adams and at Edison Investment Research, where she held various senior roles within the healthcare team. She has also worked in risk management at both Dresdner Kleinwort and Lehman Brothers, as a credit analyst focused on the financials sector.

She holds an MA in Biological Sciences (University of Oxford) and an MPhil in Bioscience Enterprise (University of Cambridge).